People
We are a highly-experienced team of drug discovery and development experts focused on making therapies happen that will change the way we age.


christian angermayer
co-founder & chairman of the board

shannon klinger
member of the board of directors

teresa deluca
md, mba
member of the board of directors

aaron weaver
cfa
member of the board of directors

gregory weaver
mba
member of the board of directors

aksana labokha
phd
chief executive officer

caleb morgret
cfa
chief financial officer

karim allam
mba, llm, ccp
chief legal & people officer

matthias steger
phd mba
co-founder

patrick schnider
phd
vp medicinal chemistry - rejuveron telomere therapeutics

prof. manuel serrano
phd
co-founder & scientific advisor - rejuveron senescence therapeutics

timothy cash
phd
co-founder & chief scientific officer - rejuveron senescence therapeutics

tristan heintz
phd
chief scientific officer - rejuveron vascular therapeutics

chien chi hsiao
phd
head of medicinal chemistry - rejuveron telomere therapeutics

marianna feretzaki
phd
chief executive officer a.i. - rejuveron telomere therapeutics
suneet agarwal
phd mba
co-founder - rejuveron telomere therapeutics

pierre-antoine mudry
bba ms
head, corporate finance and investor relations

lisa caflisch
lab operations manager & bso

dovaine picazo
executive assistant
prof. hideyuki okano
md phd
member of the scientific advisory board

prof. lee rubin
phd
co-founder - rejuveron vascular therapeutics